Streetbeat News

Products Services

AAPL

Marques Brownlee reviewed Apple's iPhone 16, highlighting its unfinished feel due to missing AI features. Despite design and performance improvements, the launch has mixed reactions, with concerns over demand and competition from Huawei.

Portfolio Pulse from Ananya Gairola

September 24, 2024 | 10:33 am

ZUO

Zuora has introduced new AI enhancements at Subscribed Live London, allowing customers to activate an AI paywall for better insights into subscriber behavior, aiming to boost conversion and revenue growth.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:13 am

NVS

Generate:Biomedicines has entered a collaboration with Novartis to develop protein therapeutics, with a potential transaction value exceeding $1 billion. Generate will receive $65 million upfront, including $15 million in equity, and is eligible for milestone payments and royalties.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:12 am

BCLI

BrainStorm Cell Therapeutics is set to present the latest updates on its NurOwn therapy at the upcoming NEALS meeting. This presentation could provide insights into the progress and potential of NurOwn, which is significant for investors tracking the company's developments.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:09 am

CPRX

Catalyst Pharmaceuticals' FIRDAPSE has been approved in Japan for treating Lambert-Eaton Myasthenic Syndrome (LEMS), marking a significant milestone for the company and its sub-licensee, DyDo Pharma. This approval expands FIRDAPSE's reach beyond the U.S., where it is already a leading therapy for LEMS.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:08 am

LLY

Eli Lilly announced that Japan has approved its drug Kisunla (Donanemab-azbt) for early symptomatic Alzheimer's disease. The approval was based on data from the TRAILBLAZER-ALZ 2 Phase 3 clinical study.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:07 am

REVB

Revelation Biosciences announced positive results from its Phase 1 Gemini trial, showing significant increases in IL-10, an anti-inflammatory protein, across various doses. This suggests potential for Gemini in treating inflammation-related conditions.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:06 am

KBR

KBR has secured a $113 million task order to conduct aeronautical systems research and development for the U.S. Air Force at Wright-Patterson Air Force Base over five years. This contract is part of the DoDIAC's multiple-award contract vehicle.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:04 am

NVVE

Nuvve Holding Corp. has launched its first electric bus charging project in New Mexico in collaboration with Las Cruces Public Schools. This project involves deploying Vehicle-to-Grid (V2G) capable chargers to support the transition to electric school buses, marking a significant step in expanding electric vehicle infrastructure in the educational sector.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:04 am

SCKT

Socket Mobile announced that its CaptureSDK and entire line of barcode scanners and NFC reader/writers are fully compatible with iOS 18 after thorough testing.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:03 am